Hep Web Exclusives
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hep Newsletter
Join Us:

Back to home » Hep Web Exclusives


October 10, 2014
FDA Approves Gilead’s Hep C Drug Harvoni (Ledipasvir/Sofosbuvir)
The FDA has approved Gilead Sciences’ hotly anticipated new hepatitis C therapy Harvoni (ledipasvir/sofosbuvir).
October 08, 2014
Hepatitis C: Treating Those at High Risk
This excerpt from the HCV Advocate discusses why it makes sense to treat those who are at high risk of transmitting hepatitis C
October 07, 2014
USCA 2014: Viral Hepatitis in the Spotlight for the First Time
Corinna Dan,
RN, MPH
An overview from the hepatitis policy advisor at the U.S. Department of Health and Human Services.
October 01, 2014
Celebrating 20 Years of Blood Safety
An overview of the 2014 National Hemophilia Foundation annual meeting.
Archives
   

October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
September 2012
July 2012
April 2012
March 2012
January 2012
December 2011
November 2011
July 2011
November 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
September 2009
September 2007


Quick Links
Current Issue
Forums
Poll
Blogs
Hep TV
Calendar
Services Directory
Conference News
Top Stories
Treatment News
Hep Exclusives
All About Hepatitis
• Hepatitis A
Transmission
Prevention
Treatment
• Hepatitis B
Transmission
Prevention
Treatment
• Hepatitis C
Transmission
Prevention
Treatment
HCV/HIV Coinfection
Help Paying For Meds
Clinical Trials
TALK TO US
Tell us what you think
Poll
Are you a regular coffee drinker?
Yes
No


Survey
Hepatitis C Reader Survey
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.